Literature DB >> 2995354

The oligosaccharide moieties of the epidermal growth factor receptor in A-431 cells. Presence of complex-type N-linked chains that contain terminal N-acetylgalactosamine residues.

R D Cummings, A M Soderquist, G Carpenter.   

Abstract

The receptor for epidermal growth factor (EGF) in the human epidermoid carcinoma cell line A-431 is a glycoprotein of apparent molecular weight = 170,000. During biosynthesis, the receptor is first detected as a precursor of apparent Mr = 160,000. In this report we describe our studies on the structures of the oligosaccharide moieties of the mature receptor and its precursor. A-431 cells were grown in medium containing radioactive sugars and the radiolabeled receptors were purified by immunoprecipitation and sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Radiolabeled glycopeptides were prepared from the purified receptor by proteolysis, and their structures were examined by a variety of techniques. The mature EGF receptor contains both complex-type and high mannose-type Asn-linked oligosaccharides in the approximate ratio of 2 to 1, while the precursor contains only high mannose-type chains. A number of experimental results demonstrate that the mature receptor does not contain oligosaccharides in O-linkage through N-acetylgalactosamine to either serine or threonine. The high mannose-type oligosaccharides in both precursor and mature receptor can be cleaved by endo-beta-N-acetylglucosaminidase H and occur in the mature receptor as Man9GlcNAc2 (6%), Man8GlcNAc2 (49%), Man7GlcNAc2 (25%), and Man6GlcNAc2 (20%), whereas, in the receptor precursor the high mannose chains occur primarily as Man8GlcNAc2 (70%). The complex-type oligosaccharides in the mature receptor are predominantly tri- or tetraantennary species and are unusual in several respects. (i) Many of the chains do not contain sialic acid, while the remaining chains contain 1-2 sialic acid residues. (ii) Half of the [3H] mannose-derived radioactivity was recovered as [3H] fucose and the remaining half as [3H] mannose, indicating that there may be an average of 3 fucose residues/chain. (iii) About one-third of the [3H] glucosamine-derived radioactivity in these glycopeptides was recovered as N-acetylgalactosamine and these residues are all alpha-linked and occur at the nonreducing termini. These data demonstrate that the complex-type Asn-linked oligosaccharides in the EGF receptor from A-431 cells contain sugar residues related to human blood type A. In light of other recent studies, these results suggest that in A-431 cells blood group determinants in surface glycoproteins are contained in Asn-linked but not O-linked oligosaccharides.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2995354

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

Review 1.  Monoclonal antibodies to epidermal growth factor receptors in studies of receptor structure and function.

Authors:  T Kawamoto; G H Sato; K Takahashi; M Nishi; S Taniguchi; J D Sato
Journal:  Cytotechnology       Date:  1990-05       Impact factor: 2.058

Review 2.  Epidermal growth factor receptor: elements of intracellular communication.

Authors:  S M Hernández-Sotomayor; G Carpenter
Journal:  J Membr Biol       Date:  1992-06       Impact factor: 1.843

3.  Role of the Sec61 translocon in EGF receptor trafficking to the nucleus and gene expression.

Authors:  Hong-Jun Liao; Graham Carpenter
Journal:  Mol Biol Cell       Date:  2007-01-10       Impact factor: 4.138

4.  Signaling from the Golgi: mechanisms and models for Golgi phosphoprotein 3-mediated oncogenesis.

Authors:  Kenneth L Scott; Lynda Chin
Journal:  Clin Cancer Res       Date:  2010-03-30       Impact factor: 12.531

5.  Heterogeneity of epidermal growth factor binding kinetics on individual cells.

Authors:  J C Chung; N Sciaky; D J Gross
Journal:  Biophys J       Date:  1997-08       Impact factor: 4.033

6.  GOLPH3 Mediated Golgi Stress Response in Modulating N2A Cell Death upon Oxygen-Glucose Deprivation and Reoxygenation Injury.

Authors:  Ting Li; Hong You; Xiaoye Mo; Wenfang He; Xiangqi Tang; Zheng Jiang; Shiyu Chen; Yang Chen; Jie Zhang; Zhiping Hu
Journal:  Mol Neurobiol       Date:  2015-01-30       Impact factor: 5.590

Review 7.  Carbohydrates as antigenic determinants of glycoproteins.

Authors:  T Feizi; R A Childs
Journal:  Biochem J       Date:  1987-07-01       Impact factor: 3.857

8.  Characterization of a novel anti-peptide antibody that recognizes a specific conformation of the platelet-derived growth factor receptor.

Authors:  S Bishayee; S Majumdar; C D Scher; S Khan
Journal:  Mol Cell Biol       Date:  1988-09       Impact factor: 4.272

Review 9.  EGFR-targeted therapies in the post-genomic era.

Authors:  Mary Jue Xu; Daniel E Johnson; Jennifer R Grandis
Journal:  Cancer Metastasis Rev       Date:  2017-09       Impact factor: 9.264

10.  Characterization of glycosylation sites of the epidermal growth factor receptor.

Authors:  Yuejun Zhen; Richard M Caprioli; James V Staros
Journal:  Biochemistry       Date:  2003-05-13       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.